Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 72 (GAPDHP72) is a processed pseudogene located in the human genome, originating from retrotransposition of the functional GAPDH mRNA[1][3]. GAPDH pseudogenes are especially abundant in mammalian genomes, with over 60 processed GAPDH pseudogenes in humans, but GAPDHP72 does not produce a functional protein and is not subject to the selective pressures that govern its parent gene[1][2][3]. Processed pseudogenes like GAPDHP72 can accumulate mutations, lack introns and functional promoters, and may sometimes participate in gene regulation as noncoding RNA, but they are not considered druggable or disease-associated targets[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 72 (GAPDHP72).